CClinicalTrials.gg
CompletedNCT02900339OSS-IRMUpdated Dec 14, 2022

Magnetic Resonance Imaging (MRI) Sequences Optimization in Healthy Subjects

An interventional study of Magnetic Resonance Imaging in Healthy Volunteers, sponsored by Rennes University Hospital. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-12-14.

Sponsored by Rennes University Hospital · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 3 years 4 months after the study started (first participant enrolled Apr 2013, registered Sep 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
628
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Magnetic resonance imaging (MRI) is a noninvasive and non-ionizing (no use of X-rays) imaging modality. Today it is considered an anatomical and functional exploration reference technique. Since its inception around 1985, this technology is constantly evolving.

Many advances in MRI require constant adaptations of radiological practices. The morphological image is now associated with functional and parametric information (infusion, diffusion spectroscopy, etc ...). In parallel, work combining acquisition and post-processing of data also open new applications (tractography, functional MRI, etc ....). Thus, more and more procedures are necessary to "integrate" these techniques for the diagnosis and adapt to new demands of clinicians.

The type of sequence and its associated parameters allow to directly influence the contrast of images, to characterize tissue compared to another and, ultimately, to highlight morphological or functional abnormality. Image quality can be optimized on each MRI, depending on the time available for the acquisition on the one hand, and on the desired resolution and contrast, on the other hand. For each sequence, it is therefore necessary to find a compromise that will optimize the diagnostic quality of the examination.

This optimization requires a phase focusing on healthy volunteers. It is therefore important that researchers and physicists could design on healthy volunteers, the best settings of all parameters for an image or spectrum. Indeed, it is always necessary to properly optimize every parameter choices before beginning a study of a cohort of patients.

In this context, the main objective of this study is to optimize sequences and imaging protocols to evaluate and validate the choice of parameters in healthy volunteers.

02

Conditions studied

  • Healthy Volunteers

Keywords

  • MRI
  • Sequence optimization
  • Healthy volunteers
03

In context

Lead sponsor

Rennes University Hospital is the lead sponsor of 440 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Men or women aged over 18 years
  • Written informed consent given

Exclusion criteria

Exclusion Criteria:

  • contraindication to MRI :

    • Claustrophobia
    • morphotype not allowing access to MRI
    • Wear a metallic implant, such as:
    • Pacemaker (pacemaker)
    • Ferromagnetic surgical clips
    • Intra orbital metallic foreign bodies or encephalic
  • Pregnancy
  • Breastfeeding
  • Adults under guardianship, trusteeship or safeguard justice
  • No social Insurance
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
628 participants (actual)

Study arms

  • Experimental
    MR parameters optimization

    The study will be conducted on the MRI of the Neurinfo platform, in the radiology department of the University Hospital of Rennes.

    Device: Magnetic Resonance Imaging

Interventions

  • DeviceMagnetic Resonance Imaging

    MRI of the Neurinfo platform is an MRI 3 Tesla Magnetom Verio model, Siemens (Siemens Healthcare, Erlangen, Germany). This imager is marked for European Conformity (CE), ensuring compliance with European Union safety standards.

    Also known as: Magnetom

06

What researchers measure

Primary outcomes

  1. Quantitative assessment of acquired sequences

    Quality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions. This evaluation will be based on quantitative criteria extracted from computer analysis of the data : signal to noise ratio, contrast-to-noise, blur level, information sharing, collocation of areas set evidenced by the different techniques, etc...

    Time frame: One day after data acquisitions

Secondary outcomes

  1. Qualitative assessment of acquired sequences

    Quality images, maps or spectra acquired with optimized parameters will be compared to standard acquisitions. This evaluation will be based on statistical comparison of visual qualitative criteria by experts radiologists

    Time frame: One day after data acquisitions

07

Study locations

1 site
  • Radiology Department CHU de Rennes
    Rennes cedex 9, 35033, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 14, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02900339
Lead sponsor
Rennes University Hospital
Responsible party
Sponsor
First posted
Sep 14, 2016
Start date
Apr 18, 2013
Primary completion
Oct 12, 2021
Completion
Oct 12, 2021
Last update
Dec 14, 2022

Study contacts

Jean-Christophe FERRE, MD, PhD
study director · CHU Rennes

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion